Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.

The recent molecular identification of two thiamine transporters, SLC19A2 (THTR1) and SLC19A3 (THTR2), has provided the opportunity to study thiamine transporter gene expression in human malignancies. We compared RNA levels of both THTR1 and THTR2 in a panel of human breast tumors and corresponding normal tissues. THTR2 RNA levels were down-regulated in breast cancer to 14% of the level found in corresponding normal tissues, while THTR1 levels were unchanged. Both thiamine transport genes were cloned and expressed in a breast cancer cell line to examine the impact of reconstituted thiamine transport gene expression on drug and radiation sensitivity and on resistance to apoptosis. THTR2-transfected breast cancer cells showed a 2.5-fold increase in specific THTR2 activity and a 3-fold increase in cytotoxicity against a bromoacetyl ester derivative of thiamine. Surprisingly, these cells also showed a 3-fold increase in sensitivity to doxorubicin and an increase in sensitivity to ionizing radiation, but no change in sensitivity to methotrexate or paclitaxel. TUNEL assays demonstrate an increase in apoptosis in THTR2-transfected cells exposed to doxorubicin and radiation, and Western blot analysis suggests that apoptosis associated with these cytotoxic stresses is mediated at least in part by a caspase-3-dependent pathway. Therefore, thiamine transporter THTR2 gene expression is down-regulated in breast cancer, which may contribute to resistance to apoptosis in these tumors.

[1]  M. Cascante,et al.  Thiamine supplementation to cancer patients: a double edged sword. , 1998, Anticancer research.

[2]  T. Stamato,et al.  Glucose-6-phosphate dehydrogenase and the oxidative pentose phosphate cycle protect cells against apoptosis induced by low doses of ionizing radiation. , 2000, Radiation research.

[3]  I. Goldman,et al.  SLC19A3 encodes a second thiamine transporter ThTr2. , 2001, Biochimica et biophysica acta.

[4]  J. Dickerson,et al.  The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. , 1976, Oncology.

[5]  S. Eng,et al.  Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. , 1991, Cancer communications.

[6]  M Cascante,et al.  The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.

[7]  T. Meitinger,et al.  A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I , 2000, Journal of medical genetics.

[8]  W. Willett,et al.  Diet and cancer: one view at the start of the millennium. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  A. Monks,et al.  Correlation of nucleoside and nucleobase transporter gene expression with antimetabolite drug cytotoxicity. , 2002, Journal of experimental therapeutics & oncology.

[10]  I. Roninson,et al.  Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation. , 2000, Cancer research.

[11]  Lucia Altucci,et al.  The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.

[12]  C. Berdanier.  Advanced Nutrition Micronutrients , 2019 .

[13]  A. Hakim,et al.  Apoptosis is restricted to the thalamus in thiamine-deficient rats. , 1997, Neuroreport.

[14]  T. Myers,et al.  Reduced folate carrier gene (RFC1) expression and anti‐folate resistance in transfected and non‐selected cell lines , 1997, International journal of cancer.

[15]  Mansoor M Ahmed,et al.  Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. , 2000 .

[16]  R. Hurt,et al.  The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition , 1989 .

[17]  M. Mohiuddin,et al.  Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53 , 2000, Cancer.

[18]  B. Gelb,et al.  Impact of the Reduced Folate Carrier on the Accumulation of Active Thiamin Metabolites in Murine Leukemia Cells* , 2001, The Journal of Biological Chemistry.

[19]  K. Cowan,et al.  A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. , 1994, The Journal of biological chemistry.

[20]  T. Stamato,et al.  Glucose-6-phosphate Dehydrogenase and the Oxidative Pentose Phosphate Cycle Protect Cellsagainst Apoptosis Induced by Low Doses of Ionizing Radiation , 2000 .

[21]  Timothy Barrett,et al.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness , 1999, Nature Genetics.

[22]  M. Cascante,et al.  Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism? , 1998, Medical hypotheses.

[23]  R. Johnstone,et al.  P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. , 1999, Blood.

[24]  Feng Gao,et al.  Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells. , 2002, American journal of physiology. Cell physiology.

[25]  P. Martin,et al.  Molecular mechanisms of thiamine utilization. , 2001, Current molecular medicine.

[26]  B. Gelb,et al.  Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome , 1999, Nature Genetics.

[27]  G. M. Taylor,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Al‐Rubeai,et al.  Role of vitamins in determining apoptosis and extent of suppression by bcl-2 during hybridoma cell culture , 2002, Apoptosis.

[29]  Ellis J. Neufeld,et al.  The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter , 1999, Nature Genetics.

[30]  A. Stagg,et al.  Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. , 1999, The Journal of clinical investigation.

[31]  B. Wlodarczyk,et al.  Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. , 2000, Molecular genetics and metabolism.